ONC FY 2024 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$33B

FY 2024 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$3.8B+55.0% YoY

Gross Profit

$3.2B84.4% margin

Operating Income

-$568M-14.9% margin

Net Income

-$645M-16.9% margin

EPS (Diluted)

$-6.12

Cash Flow

Operating Cash Flow

-$141M

Free Cash Flow

-$670M

Stock-Based Comp.

$442M

Balance Sheet

Total Assets

$5.9B

Total Liabilities

$2.6B

Stockholders' Equity

$3.3B

Cash & Equivalents

$2.6B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.8B	$2.5B	+55.0%
Gross Profit	$3.2B	$2.1B	+54.7%
Operating Income	-$568M	-$1.2B	+53.0%
Net Income	-$645M	-$882M	+26.9%